CHLL vs. PXS, STX, VLG, SNG, ABDX, GENI, INHC, KNB, IHC, and DEST
Should you be buying Chill Brands Group stock or one of its competitors? The main competitors of Chill Brands Group include Provexis (PXS), Shield Therapeutics (STX), Venture Life Group (VLG), Synairgen (SNG), Abingdon Health (ABDX), GENinCode (GENI), Induction Healthcare Group (INHC), Kanabo Group (KNB), Inspiration Healthcare Group (IHC), and Destiny Pharma (DEST). These companies are all part of the "medical" sector.
Provexis (LON:PXS) and Chill Brands Group (LON:CHLL) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their risk, community ranking, institutional ownership, profitability, earnings, dividends, media sentiment, valuation and analyst recommendations.
Provexis received 55 more outperform votes than Chill Brands Group when rated by MarketBeat users. However, 66.67% of users gave Chill Brands Group an outperform vote while only 64.21% of users gave Provexis an outperform vote.
In the previous week, Chill Brands Group had 2 more articles in the media than Provexis. MarketBeat recorded 2 mentions for Chill Brands Group and 0 mentions for Provexis. Provexis' average media sentiment score of 0.12 beat Chill Brands Group's score of 0.00 indicating that Chill Brands Group is being referred to more favorably in the news media.
Provexis has higher earnings, but lower revenue than Chill Brands Group.
Chill Brands Group has a net margin of 0.00% compared to Chill Brands Group's net margin of -83.03%. Chill Brands Group's return on equity of -75.88% beat Provexis' return on equity.
6.4% of Provexis shares are owned by institutional investors. Comparatively, 0.0% of Chill Brands Group shares are owned by institutional investors. 21.4% of Provexis shares are owned by insiders. Comparatively, 24.0% of Chill Brands Group shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
Provexis has a beta of 1.19, meaning that its share price is 19% more volatile than the S&P 500. Comparatively, Chill Brands Group has a beta of 0.85, meaning that its share price is 15% less volatile than the S&P 500.
Summary
Provexis beats Chill Brands Group on 7 of the 13 factors compared between the two stocks.
Get Chill Brands Group News Delivered to You Automatically
Sign up to receive the latest news and ratings for CHLL and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding CHLL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Chill Brands Group Competitors List
Related Companies and Tools
